<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-109615-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">La plateforme de modification g&#xE9;n&#xE9;tique CRISPR/cas9 pour am&#xE9;liorer le rendement des vaccins dans les lign&#xE9;es cellulaires aviaires &#x2013; Phase 2</narrative>
   <narrative xml:lang="EN">Use of CRISPR/cas9 gene editing for increased vaccine yields in avian cell lines - Phase 2</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Les maladies aviaires entra&#xEE;nent des pertes &#xE9;conomiques d&#xE9;vastatrices pour les petits &#xE9;leveurs du monde entier. Les &#x153;ufs de poule embryonn&#xE9;s restent la principale plateforme de production de vaccins pour la volaille dans le monde entier, malgr&#xE9; des limites &#xE9;videntes. Ces &#x153;ufs sont g&#xE9;n&#xE9;ralement chers et principalement import&#xE9;s, ce qui limite l&#x2019;acc&#xE8;s aux vaccins pour les petits &#xE9;leveurs en raison de leur prix &#xE9;lev&#xE9;. Tout aussi importantes sont les consid&#xE9;rations &#xE9;thiques li&#xE9;es &#xE0; l&#x2019;utilisation des &#x153;ufs de poule embryonn&#xE9;s et &#xE0; la quantit&#xE9; importante de d&#xE9;chets d&#x2019;&#x153;ufs qui est produite &#x2013; une question de co&#xFB;t critique, en particulier pour les pays &#xE0; faibles et moyens revenus. En outre, l&#x2019;offre des &#x153;ufs de poule embryonn&#xE9;s, en particulier pendant les pand&#xE9;mies virales aviaires, est limit&#xE9;e, ce qui r&#xE9;duit la capacit&#xE9; &#xE0; r&#xE9;pondre &#xE0; toute menace &#xE9;mergente.

L&#x2019;am&#xE9;lioration de la production de vaccins &#xE0; partir de la culture cellulaire est d&#xE9;sormais une alternative majeure pour l&#x2019;industrie des vaccins pour la volaille en g&#xE9;n&#xE9;ral. L&#x2019;objectif de ce projet est d&#x2019;am&#xE9;liorer les rendements viraux en supprimant la barri&#xE8;re protectrice qui inhibe la reproduction de plusieurs virus hautement pathog&#xE8;nes pour l&#x2019;animal et l&#x2019;humain, dont le virus Ebola, la grippe et le VIH. Apr&#xE8;s l&#x2019;ach&#xE8;vement d&#x2019;une premi&#xE8;re phase r&#xE9;ussie, ce projet fera avancer la recherche vers un prototype final de lign&#xE9;e cellulaire modifi&#xE9;e qui peut attirer un d&#xE9;veloppement industriel et une commercialisation suppl&#xE9;mentaire. 

Cette nouvelle technologie pourrait r&#xE9;duire consid&#xE9;rablement les co&#xFB;ts de production des vaccins. En outre, elle peut &#xEA;tre utilis&#xE9;e dans de nombreux autres syst&#xE8;mes de production de vaccins existants, ce qui permet d&#x2019;am&#xE9;liorer la disponibilit&#xE9; des vaccins contre un large &#xE9;ventail de maladies du b&#xE9;tail qui sont importantes pour les petits exploitants des pays en d&#xE9;veloppement.

Ce projet est soutenu gr&#xE2;ce au Fonds d&#x2019;innovation en vaccins pour le b&#xE9;tail (FIVB), un partenariat entre la Fondation Bill et Melinda Gates, Affaires mondiales Canada et le CRDI. Le fonds repr&#xE9;sente un investissement conjoint de 57 millions de CAD sur cinq ans visant &#xE0; financer le d&#xE9;veloppement, la production et la commercialisation de vaccins innovants contre les maladies du b&#xE9;tail prioritaires en Afrique subsaharienne, en Asie du Sud et en Asie du Sud-Est.</narrative>
   <narrative xml:lang="EN">Poultry diseases cause devastating economic losses for small-scale livestock farmers globally. Embryonated chicken eggs (ECE) remain the main platform for poultry vaccine production worldwide despite clear limitations. These eggs are generally expensive and mostly imported, thus limiting access to vaccines by smallholder livestock farmers due to high pricing. Equally important are the ethical considerations of using ECE and the significant amount of egg waste that is produced &#x2014; a critical cost issue, especially for low- and middle-income countries. In addition, ECE supply, especially during avian viral pandemics, is restricted, which reduces the ability to respond to any emerging threat.

Improved cell culture-based vaccine production is now a major alternative for the poultry vaccine industry in general. The objective of this project is to improve viral yields by removing the protective barrier that inhibits the replication of several highly pathogenic animal and human viruses, including Ebola, influenza, and HIV. Following the completion of a successful first phase, this project will advance the research towards a final modified cell line prototype that can attract further industry development and commercialization. 

This novel technology could significantly reduce vaccine production costs. Further, it has the potential for application in many other existing vaccine production systems, thus enhancing vaccine availability for a wide range of livestock diseases that are significant for smallholders in developing countries.

This project is supported through the Livestock Vaccine Innovation Fund, a partnership of the Bill &amp; Melinda Gates Foundation, Global Affairs Canada, and IDRC. The Fund represents a joint investment of CA$57 million over five years to support the development, production, and commercialization of innovative vaccines against priority livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
   <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="24">
   <narrative xml:lang="EN">The Pirbright Institute</narrative>
  </participating-org>
  <participating-org role="4" type="24">
   <narrative xml:lang="EN">The Pirbright Institute</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-01-01" type="2"></activity-date>
  <activity-date iso-date="2023-04-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="2"></activity-scope>
  <recipient-region code="289" percentage="50" vocabulary="1"></recipient-region>
  <recipient-region code="679" percentage="50" vocabulary="1"></recipient-region>
  <sector code="2" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Increasing food security</narrative>
   <narrative xml:lang="FR">S&#xE9;curit&#xE9; alimentaire</narrative>
  </sector>
  <sector code="31182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="CAD" value-date="2021-02-11">590863</value>
   <provider-org>
    <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="CAD" value-date="2021-02-11">323547</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
    <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="CAD" value-date="2021-02-11">261490</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="CAD" value-date="2021-02-11">118121</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="CAD" value-date="2021-02-11">215713</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="CAD" value-date="2021-02-11">95465</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-08-30"></transaction-date>
   <value currency="CAD" value-date="2021-08-30">107307</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-08-30"></transaction-date>
   <value currency="CAD" value-date="2021-08-30">195966</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-08-30"></transaction-date>
   <value currency="CAD" value-date="2021-08-30">86726</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Pirbright Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
